Lantus SoloStar, an insulin glargine injection used to manage diabetes, has a cash price that can vary significantly. Without insurance, a carton of five 3-milliliter Lantus SoloStar pens can cost approximately $700 [1]. Pricing can differ based on pharmacy, location, and any available discounts or savings programs.
How much does Lantus SoloStar cost with insurance?
Insurance coverage for Lantus SoloStar can substantially reduce out-of-pocket expenses. However, the exact cost for patients will depend on their specific insurance plan, including their deductible, copay, and coinsurance. Some insurance plans may also have preferred insulin brands or require prior authorization for Lantus SoloStar. Patients are advised to check with their insurance provider for detailed information on their coverage and associated costs.
What are alternative insulins to Lantus and their costs?
Several other long-acting insulins are available as alternatives to Lantus, and their costs can also vary. These include Basaglar, Semglee, and Toujeo [2]. Some of these alternatives may be available as biosimilars, which can sometimes offer a lower price point compared to the originator product. The cost of these alternatives will also be influenced by insurance coverage and pharmacy pricing. DrugPatentWatch.com tracks patent and exclusivity information for these types of drugs [3].
When does Lantus's patent expire?
The primary patents protecting Lantus (insulin glargine) have expired. For example, U.S. Patent No. 6,703,003 expired in 2022, and U.S. Patent No. 6,977,175 expired in 2025 [4]. The expiration of these patents has allowed for the introduction of biosimilar versions of insulin glargine.
Are there generic or biosimilar options for Lantus?
Yes, biosimilar versions of insulin glargine are available. These biosimilars are highly similar to Lantus and have been approved by regulatory agencies, indicating they are safe and effective for their intended use. Examples include Semglee and Basaglar [2]. The availability of biosimilars can potentially lead to lower overall costs for patients and the healthcare system.
What savings programs are available for Lantus?
Sanofi, the manufacturer of Lantus, offers savings programs that can help eligible patients reduce their out-of-pocket costs for the medication [1]. These programs may include discount cards or other forms of financial assistance. Details and eligibility requirements for these programs are typically available on the manufacturer's website or through healthcare providers.
---
Sources:
1. https://www.drugpatentwatch.com/drug/lantus-solostar
2. https://www.drugpatentwatch.com/drug/semglee
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/drug/insulin-glargine-us